[Gender dysphoria in children and preadolescents: state of the art. Review and ethical assessment of therapeutic strategies].

IF 0.2 Q4 ETHICS
María Font, Natalia López-Moratalla
{"title":"[Gender dysphoria in children and preadolescents: state of the art. Review and ethical assessment of therapeutic strategies].","authors":"María Font, Natalia López-Moratalla","doi":"10.30444/CB.204","DOIUrl":null,"url":null,"abstract":"<p><p>Gender dysphoria (GD) can be defined as a persistent and intense experience of incongruence between biological sex and perceived gender identity, accompanied by significant distress and, frequently, an explicit desire to modify bodily characteristics. In the current scientific context, the study of GD is structured around several lines of research, including the possible existence of neurobiological differences between cisgender children/pre-adolescents (controls) and transgender individuals, alterations in the networks involved in body self-perception, and the potential contribution of biological factors - including genetic components - to the development of transsexuality, as has been demonstrated in some adult trans individuals, as well as to gender identity more broadly. In the clinical domain, interventions aimed at children and pre-adolescents with GD - primarily based on the administration of puberty blockers, followed in some cases by cross-sex hormone therapies and, exceptionally, surgical interventions - raise specific questions that go beyond those already identified in adult populations. These issues are particularly related to the role played by sex hormones in brain development during critical stages of neurodevelopment, as well as to the potential long-term effects on endocrine systems and reproductive function. The analysis of the available evidence on side effects, together with consideration of their potentially irreversible nature in certain cases, highlights the need for especially rigorous ethical evaluation. In this regard, the principle of primum non nocere assumes central importance, given that significant uncertainties remain as to whether the potential benefits of these interventions outweigh their inherent risks. Likewise, it is essential to ensure an interpretation of scientific data free from ideological bias, as well as to reinforce the requirement for a comprehensive diagnostic approach encompassing endocrinological, psychological, and social dimensions. This is further compounded by the critical issue of the validity of informed consent in minors, particularly in relation to their level of maturity. Finally, recent advances in the study of genetic bases and in the understanding of the neural networks involved in bodily self-perception open up the possibility of new therapeutic approaches, the exploration of which requires deeper and more systematic scientific development.</p>","PeriodicalId":42510,"journal":{"name":"Cuadernos de Bioetica","volume":"37 120","pages":"183-214"},"PeriodicalIF":0.2000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cuadernos de Bioetica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30444/CB.204","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ETHICS","Score":null,"Total":0}
引用次数: 0

Abstract

Gender dysphoria (GD) can be defined as a persistent and intense experience of incongruence between biological sex and perceived gender identity, accompanied by significant distress and, frequently, an explicit desire to modify bodily characteristics. In the current scientific context, the study of GD is structured around several lines of research, including the possible existence of neurobiological differences between cisgender children/pre-adolescents (controls) and transgender individuals, alterations in the networks involved in body self-perception, and the potential contribution of biological factors - including genetic components - to the development of transsexuality, as has been demonstrated in some adult trans individuals, as well as to gender identity more broadly. In the clinical domain, interventions aimed at children and pre-adolescents with GD - primarily based on the administration of puberty blockers, followed in some cases by cross-sex hormone therapies and, exceptionally, surgical interventions - raise specific questions that go beyond those already identified in adult populations. These issues are particularly related to the role played by sex hormones in brain development during critical stages of neurodevelopment, as well as to the potential long-term effects on endocrine systems and reproductive function. The analysis of the available evidence on side effects, together with consideration of their potentially irreversible nature in certain cases, highlights the need for especially rigorous ethical evaluation. In this regard, the principle of primum non nocere assumes central importance, given that significant uncertainties remain as to whether the potential benefits of these interventions outweigh their inherent risks. Likewise, it is essential to ensure an interpretation of scientific data free from ideological bias, as well as to reinforce the requirement for a comprehensive diagnostic approach encompassing endocrinological, psychological, and social dimensions. This is further compounded by the critical issue of the validity of informed consent in minors, particularly in relation to their level of maturity. Finally, recent advances in the study of genetic bases and in the understanding of the neural networks involved in bodily self-perception open up the possibility of new therapeutic approaches, the exploration of which requires deeper and more systematic scientific development.

儿童和青春期前的性别焦虑:最新进展。治疗策略的回顾与伦理评价[j]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.70
自引率
20.00%
发文量
5
期刊介绍: La revista Cuadernos de Bioética, órgano oficial de la Asociación Española de Bioética y Ética Médica, publica cuatrimestralmente artículos y recensiones bibliográficas sobre todas las áreas de la bioética: fundamentación, ética de la investigación, bioética clínica, biojurídica, etc. Estos proceden de los aceptados en la revisión tutelada por los editores de la revista como de otros que por encargo el comité editorial solicite a sus autores. La edicion de la revista se financia con las aportaciones de los socios de AEBI.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书